RT Drop Site (@DropSiteNews)💢 SECOND PHARMA PLANT HIT: Israeli-U.S. Strikes Target Major Medicine Supplier in Western TehranA second major pharmaceutical facility in western Tehran was struck Tuesday in the latest wave of Israeli-U.S. airstrikes, according to AFP and Al Arabiya reports.🔹The Daro Bakhsh Pharmaceutical Factory, one of Iran’s oldest and most critical medical production hubs, sustained damage after residents reported “loud explosions” in the area. Full damage assessments are ongoing.The facilit ...

Group 1 - Bausch Health Companies Inc. (NYSE:BHC) is recognized as one of the 7 best small-cap drug manufacturing stocks to buy according to hedge funds [1] - Analyst Glen Santangelo from Barclays reduced the price target on Bausch Health from $8 to $7, maintaining an Equal Weight rating, indicating an adjusted upside potential of almost 37% despite the revision [1][2] - The company's fourth quarter report showed year-on-year growth in key financial metrics, attributed to its commercial and operational strength [3] Group 2 - CEO Thomas Appio highlighted the potential of the newly acquired full-service aesthetics distribution business in China, which enhances the company's geographical reach and customer access [3] - Bausch Health operates in various segments including hepatology, neurology, dermatology, gastroenterology, generic pharmaceuticals, over-the-counter items, aesthetic medical devices, and eye health [3] - The company is committed to commercial and operational excellence and aims to expand its portfolio and enhance its long-term outlook as it moves into 2026 [3]

Novartis said last year it would invest $23 billion to build and expand 10 facilities in the US https://t.co/6EkdKVtPqi ...

Group 1: Disney - Disney has appointed Josh D'Amaro as the new CEO, effective March 18, succeeding Bob Iger. D'Amaro has nearly three decades of experience at Disney and previously chaired the experiences division, which recently achieved $10 billion in quarterly revenue for the first time [2][5] - Disney's stock has declined over 40% in the past five years, contrasting with the S&P 500's increase of over 80% during the same period [5] Group 2: Chipotle - Chipotle's shares fell more than 5% after reporting a decline in traffic for the fourth consecutive quarter, with same-store sales down 1.7% in 2025, marking its first annual drop since 2016. The company anticipates flat same-store sales in 2026 [3][4] - Over the last 12 months, Chipotle's shares have decreased nearly 33%, prompting the company to introduce "protein cups" and slow down price increases to attract customers [4] Group 3: Novo Nordisk - Novo Nordisk expects a decline in sales and profit growth this year, leading to a drop of over 14% in U.S.-listed shares, marking the worst day in about six months. The forecast is impacted by a deal with the Trump administration to cut prices and loss of exclusivity for its drugs [10][11] - CEO Mike Doustdar indicated that the company's situation may worsen before it improves, contributing to the negative outlook [11] Group 4: Eli Lilly - Eli Lilly's shares rose more than 8% in premarket trading after exceeding analyst expectations in the fourth quarter. The company also provided a stronger-than-anticipated full-year revenue outlook, driven by high demand for its drugs Zepbound and Mounjaro [12]

Group 1: Market Performance - The FTSE 100 reached a record high of 10,342 points, closing up 1.15% despite declines in gold and oil prices [4][6][8] - The FTSE 250 also hit a four-year high of 23,426 points, indicating strong performance in the mid-cap sector [6][8] - European stocks rallied, with France's CAC rising 0.8% and Germany's DAX advancing 1.1%, while the continent-wide Stoxx 600 index climbed just over 1% [9] Group 2: Commodity Prices - Gold prices fell sharply, down 3.6% to $4,649 an ounce, compared to nearly $5,600 the previous week, marking a significant decline [5][53] - Silver experienced a dramatic drop, plunging 30% on Friday and an additional 7% to $78.47, far below its record high of $121 [5][53] - Brent crude oil prices decreased nearly 5% to $66 a barrel, influenced by geopolitical developments and market sentiment [5][62] Group 3: Natural Gas Market - US natural gas futures dropped 26% to $3.21 per million British thermal units, marking the largest decline in 29 years due to forecasts for warmer weather [2] - Europe's TTF benchmark gas price fell 16.5% to €33.32 per megawatt-hour, easing supply concerns amid milder temperature predictions [2] Group 4: Bitcoin and Cryptocurrency - Bitcoin hit a 10-month low, falling below $80,000, with significant losses attributed to a broader market sell-off [3][50] - The CEO of the UK's largest Bitcoin company reported a loss of nearly $100 million but expressed intentions to continue purchasing Bitcoin [11][12] Group 5: Federal Reserve and Economic Outlook - The nomination of Kevin Warsh as the next Federal Reserve chairman has led to market volatility, with expectations of tighter monetary policy impacting investor sentiment [20][43] - Analysts predict that Warsh may lower interest rates while simultaneously reducing the Fed's balance sheet, aiming to support economic growth without increasing inflation [35][38]

Eli Lilly plans to open a $3.5 billion plant in Pennsylvania’s Lehigh Valley, giving the region an economic shot in the arm https://t.co/J59LsrWlVx ...

I'm thrilled to be joined by the leaders of nine of the world's largest pharmaceutical manufacturers. All very big names, celebrities in their own right, very very powerful people, and they head some of the most uh admired companies anywhere in the world. It's a great group to announce that they've agreed to offer many of their flagship drugs, really all of their flagship drugs at heavily discounted, most favored nations prices.In other words, whatever the drug sells for over the world in the world, whateve ...

Economic Indicators - New evidence indicates that China's economic troubles are deepening, with consumption, investment, and industrial output data all falling short of expectations [1] Legal and Regulatory Developments - A Hong Kong court found pro-democracy activists and media baron Jimmy Lie guilty of sedition and collusion with foreign countries under the national security law, impacting market sentiment [1] Pharmaceutical Industry - A French drug maker has flagged another delay regarding a US regulatory decision on its experimental multiple sclerosis drug, alongside disappointing latest stage study results that caused a decline of over 1% in premarket trading [2] Mergers and Acquisitions - Service Now is in discussions to acquire cybersecurity startup Armis, indicating ongoing consolidation in the cybersecurity sector [2] Entertainment Industry - Disney's animated sequel Zootopia 2 has topped the box office, earning over $26 million in its opening weekend and surpassing the $1 billion mark in worldwide gross [3]

Group 1 - Warner Brothers Discovery may see an increase in its share price as both Netflix and Paramount Sky Dance have indicated their capability to raise bids for the media company [1] - Longtime media investor Mario Gabelli is likely to tender his clients' shares of Warner Brothers Discovery to Paramount to initiate a bidding war [1] Group 2 - Nvidia supplier SK Hynix is considering a dual listing of its shares in the US alongside its current listing in South Korea, resulting in a nearly 4% increase in its shares [2] - Disney has nominated former Apple executive Jeff Williams to join its board, expanding the board to 11 members [2][3] - Eli Lilly plans to invest $6 billion in building a manufacturing plant in Alabama to boost production of its experimental anti-obesity pill and other drugs [3] Group 3 - European food delivery giant HelloFresh is evaluating strategic options, which may include partnerships in certain countries and capital allocation measures [4]

Pharmaceutical Innovations and Regulatory Submissions - Eli Lilly's drug Jaypirca (pirtobrutinib) achieved an 80% risk reduction in progression or death for treatment-naïve chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) patients in the Phase 3 BRUIN CLL-313 trial, marking a significant advancement in cancer therapy [2][7] - Johnson & Johnson submitted a supplemental Biologics License Application (sBLA) for the combination of Tecvayli and Darzalex for treating relapsed/refractory multiple myeloma (RRMM) [3][7] Global Market Forecasts and AI Sector Deals - JPMorgan projects emerging equities to outperform developed markets in 2026, driven by a weaker or stable U.S. dollar, and identifies Chinese AI stocks as more affordable compared to U.S. counterparts, indicating potential investment opportunities [4][7] - Anthropic and Accenture announced a partnership aimed at providing advanced AI solutions to business clients [5][7] Consumer Spending Trends and Economic Commentary - Walmart's CEO Doug McMillon highlighted ongoing financial pressure on lower-income consumers despite low single-digit inflation, attributing it to cumulative price increases over the years [6][7] Geopolitical and Monetary Policy Updates - The Swiss National Bank is expected to maintain its main interest rate at 0%, but there are speculations that potential U.S. tariffs could lead to negative interest rates in the future [9][7]